Meningococcal Group ACYW135 Polysaccharide Conjufate Vaccine

Strength: 0.5ml/dose

Dosage Form: Powder and solvent for solution for Injection

Dosage and Administration: Immunication should be carried out by Intramuscular injection only. Preferably into the deltoid muscle.

Therapeutic Indication: Active immunization of individuals from the age of 12 months and above against invasive meningococcal diseases caused by Neisseria meningitides group A,C,W-135 and Y.



Precautions when using:

Copyright © 2019 凯发网站集团有限公司. All rights reserved. ICP证0301